Department of Medical Pharmacology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey
Department of Cardiology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey.
Eur J Hosp Pharm. 2021 Nov;28(6):320-324. doi: 10.1136/ejhpharm-2019-002078. Epub 2019 Oct 17.
Our previous retrospecive study evaluating the appropriateness of serum digoxin concentration (SDC) measurements revealed errors in the timing of blood specimen collection in 98% of the tests. The aim of this study is to evaluate the appropriateness of the SDC measurements and the factors involved in inappropriate test-ordering, after training health personnel in digoxin therapeutic drug monitoring.
This is a training-based quasi-experimental study. The residents and nurses of the Cardiology Clinic were trained first in December 2017, and refresher training courses were carried out every month throughout the study. The medical data of the inpatients receiving digoxin therapy were recorded prospectively, between January and December 2018. The appropriateness of the physicians' orders for SDC measurement was evaluated according to the criteria of the right indication and right timing of blood collection. The results are presented by descriptive statistics, Student's t-test and χ analysis.
A total of 232 SDC tests were ordered for 121 patients (age: 71.0±12.6 years, 56.2% women). Of these orders,129 (55.6%) were considered appropriate: 205 (88.4%) for indication and 129 (62.9%) for blood collection timing. There was a significant correlation between inappropriate order for SDC test and the age of the patient, female gender, impairment of renal function tests, high levels of serum BNP and the number of medications used (P<0.005).
Approximately a one-half decrease in inappropriate tests compared with our previous study results imply that education has a positive effect on physician behaviour. However, physicians' concerns due to increased risk factors for the patient still play a role in inappropriate test-ordering.
我们之前的回顾性研究评估了血清地高辛浓度(SDC)测量的适宜性,结果显示 98%的检测中存在采血时机错误。本研究旨在评估在对地高辛治疗药物监测的医务人员进行培训后,SDC 测量的适宜性以及导致不适当检验医嘱的因素。
这是一项基于培训的准实验研究。2017 年 12 月,心内科的住院医师和护士首先接受了培训,并在整个研究期间每月进行一次复习培训课程。前瞻性地记录了 2018 年 1 月至 12 月接受地高辛治疗的住院患者的医疗数据。根据采集血样的正确适应证和正确时机的标准,评估医师开具 SDC 检测医嘱的适宜性。结果以描述性统计、学生 t 检验和卡方检验呈现。
共为 121 名患者(年龄:71.0±12.6 岁,56.2%为女性)开具了 232 次 SDC 检测。其中 129 次(55.6%)被认为是适当的:205 次(88.4%)为适应证,129 次(62.9%)为采血时机。SDC 检测医嘱不适当与患者年龄、女性性别、肾功能检查受损、血清 BNP 水平升高以及使用药物数量有关(P<0.005)。
与我们之前的研究结果相比,不适当的检测数量减少了约一半,这表明教育对地高辛治疗药物监测医师的行为有积极影响。然而,由于患者的风险因素增加,医生的担忧仍然在不适当的检验医嘱中起作用。